Green Valley Drug To Market SinoFresh Homeopathic Antiseptic Nasal Spray

Venice, Florida – JANUARY 3, 2011 – SinoFresh®HealthCare, Inc., (PINKSHEETS: SFSH.PK) is pleased to announce that its marketing division has secured an agency marketing relationship with Green Valley Drug,  the largest medical supplier in Southern Nevada with a significant pharmacy and medical customer base in the western U.S.

 Green Valley Drug is based in a 22,000-square-foot, custom-built facility. The facility includes a comprehensive pharmacy, a sterile clean room and a warehouse that hubs approximately 18,000 sq.ft. of inventory. Green Valley stocks over 2,500 different products in the Las Vegas warehouse and can customize inventory for specific customer needs throughout the country.

“This is a tremendous step forward for our company,” states SFSH CEO, David R. Olund. “Marketing is the key element in terms of revenue production as we look to expand sales of our unique premiere product, SinoFresh Homeopathic Antiseptic Nasal Spray which targets the 37 Million sinusitis sufferers in America. Green Valley Drug brings much to the table, supplying a wide range of business outlets in the Western United States including independent and cooperative pharmacies, home health agencies, dental offices, long-term care facilities and more; everything from small practices to large surgery centers. We are thrilled to be working with Green Valley and having the opportunity to expand our national distribution reach with such a paramount organization.”


SinoFresh HealthCare, Inc. is a publicly traded company (PINKSHEETS:SFSH.PK) based in Venice, Florida, that manufactures and distributes nasal, oral and topical antiseptic germ-killing products. SinoFresh products are marketed and distributed globally through a network of strategic wholesale and retail partners. SinoFresh Healthcare, Inc’s, premier product, SinoFresh Antiseptic Homeopathic Nasal spray has in laboratory tests shown effective antiseptic capability against a variety of pathogens such as MRSA, E-Coli, H1N1 and a broad range of other viruses, molds, fungi and bacteria. 

 This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Our forward-looking statements express our current expectations or forecasts of possible future results or events, including projections of future performance, statements of management’s plans and objectives, future contracts, and forecasts of trends and other matters. Forward-looking statements speak only as of the date of this filing, and we undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur. You can identify these statements by the fact that they do not relate strictly to historic or current facts and often use words such as “anticipate”, “estimate”, “expect”, “believe”, “will likely result”, “outlook”, “project” and other words and expressions of similar meaning. No assurance can be given that the results in any forward-looking statements will be achieved and actual results could be affected by one or more factors, which could cause them to differ materially. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act.


SinoFresh HealthCare Inc.
Investor Relations
941.375.8174 option 8